New paper
Induced Tr1 cells offer new hope for treating chronic neuroinflammation and neurodegeneration (Mayo et.al Brain, 2016).
Induced Tr1 cells offer new hope for treating chronic neuroinflammation and neurodegeneration (Mayo et.al Brain, 2016).
Dr. Lior Mayo has been awarded the National Multiple Sclerosis Society Career Transition Award.
Research positions at all levels (MSc, PhD, and Postdocs) are available now. If you are passionate about scientific research and innovation, and are motivated, ambitious and driven; we want you to be part of our team.